Catalysts for $NVS
563 tracked
Feb 24, 2017
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Sep 27, 2016
approval
GLEEVEC (IMATINIB MESYLATE) — FDA approval
Imatinib Mesylate Shilpa
→
Aug 30, 2016
approval
KESIMPTA (OFATUMUMAB) — FDA approval
KESIMPTA
→
Aug 25, 2016
approval
GLEEVEC (IMATINIB MESYLATE) — FDA approval
Imatinib Mesylate Shilpa
→
Aug 25, 2016
approval
GLEEVEC (IMATINIB MESYLATE) — FDA approval
Imatinib Mesylate Shilpa
→
Jul 14, 2016
approval
SANDIMMUNE (CYCLOSPORINE) — FDA approval
Restasis
→
Jul 8, 2016
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 17, 2016
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Jun 17, 2016
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jun 16, 2016
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
May 6, 2016
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Jan 19, 2016
approval
KESIMPTA (OFATUMUMAB) — FDA approval
KESIMPTA
→
Jan 15, 2016
approval
COSENTYX (SECUKINUMAB) — FDA approval
NOVARTIS AG
→
Jan 15, 2016
approval
COSENTYX (SECUKINUMAB) — FDA approval
NOVARTIS AG
→
Jan 6, 2016
approval
SANDIMMUNE (CYCLOSPORINE) — FDA approval
Restasis
→
Nov 20, 2015
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
Nov 20, 2015
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Nov 2, 2015
approval
SANDIMMUNE (CYCLOSPORINE) — FDA approval
Restasis
→
Oct 30, 2015
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 28, 2015
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 28, 2015
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 28, 2015
approval
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Apr 14, 2015
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Mar 31, 2015
approval
SANDIMMUNE (CYCLOSPORINE) — FDA approval
Restasis
→
Mar 31, 2015
approval
SANDIMMUNE (CYCLOSPORINE) — FDA approval
Restasis
→
Mar 31, 2015
approval
SANDIMMUNE (CYCLOSPORINE) — FDA approval
Restasis
→
Jan 30, 2015
approval
GLEEVEC (IMATINIB MESYLATE) — FDA approval
Imatinib Mesylate Shilpa
→
Jan 21, 2015
approval
COSENTYX (SECUKINUMAB) — FDA approval
NOVARTIS AG
→
Sep 26, 2014
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Sep 16, 2014
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→